Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1993 May;46(5):437–440. doi: 10.1136/jcp.46.5.437

Use of Probemix and OmniProbe biotinylated cDNA probes for detecting HPV infection in biopsy specimens from the genital tract.

I Zehbe 1, E Rylander 1, A Strand 1, E Wilander 1
PMCID: PMC501253  PMID: 8391549

Abstract

AIMS--To compare two commercially available pan probes for the identification of human papillomavirus (HPV) DNA expression in histological sections and to type the HPV positive cases. METHODS--97 formalin fixed, paraffin wax embedded biopsy specimens from the genital tract were tested for HPV positivity with in situ hybridisation using biotinylated cDNA pan probes--Probemix (Enzo) and OmniProbe (Digene). The HPV positive cases were further tested with HPV types 6/11, 16/18, and 31/33/35/51, and the HPV type was related to the histological diagnosis. Formalin fixed, HeLa cells (10-50 HPV 18 copies per cell) and SiHa cells (1-2 HPV 16 copies per cell) were used as reference cell lines. RESULTS--32% of the specimens gave positive nucleic signals with both Probemix and OmniProbe. Of these, 84% could be further characterised with regard to HPV types 6/11, 16/18, and 31/33/35/51; 4% of all cases were positive with either Probemix or OmniProbe. The concordance of these probes was high, 96% altogether. HeLa cells stained positive but SiHa cells did not. CONCLUSION--There is no difference between Probemix and OmniProbe for the general detection of HPV. The mean detection limit of these probes is about 20 copies a cell.

Full text

PDF
437

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Nuovo G. J., Friedman D., Richart R. M. In situ hybridization analysis of human papillomavirus DNA segregation patterns in lesions of the female genital tract. Gynecol Oncol. 1990 Feb;36(2):256–262. doi: 10.1016/0090-8258(90)90184-m. [DOI] [PubMed] [Google Scholar]
  2. Nuovo G. J., Gallery F., MacConnell P., Becker J., Bloch W. An improved technique for the in situ detection of DNA after polymerase chain reaction amplification. Am J Pathol. 1991 Dec;139(6):1239–1244. [PMC free article] [PubMed] [Google Scholar]
  3. Reid R., Campion M. J. The biology and significance of human papillomavirus infections in the genital tract. Yale J Biol Med. 1988 Jul-Aug;61(4):307–325. [PMC free article] [PubMed] [Google Scholar]
  4. Unger E. R., Hammer M. L., Chenggis M. L. Comparison of 35S and biotin as labels for in situ hybridization: use of an HPV model system. J Histochem Cytochem. 1991 Jan;39(1):145–150. doi: 10.1177/39.1.1845759. [DOI] [PubMed] [Google Scholar]
  5. Warford A. In situ hybridisation: a new tool in pathology. Med Lab Sci. 1988 Oct;45(4):381–394. [PubMed] [Google Scholar]
  6. Wikström A., Hedblad M. A., Johansson B., Kalantari M., Syrjänen S., Lindberg M., von Krogh G. The acetic acid test in evaluation of subclinical genital papillomavirus infection: a comparative study on penoscopy, histopathology, virology and scanning electron microscopy findings. Genitourin Med. 1992 Apr;68(2):90–99. doi: 10.1136/sti.68.2.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Zehbe I., Rylander E., Strand A., Wilander E. In situ hybridization for the detection of human papillomavirus (HPV) in gynaecological biopsies. A study of two commercial kits. Anticancer Res. 1992 Sep-Oct;12(5):1383–1388. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES